Patents by Inventor Peter Marie Z. DE PORRE

Peter Marie Z. DE PORRE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF UROTHELIAL CARCINOMA
    Publication number: 20220175768
    Abstract: Described herein methods of treating urothelial carcinoma with an approved drug product containing a fibroblast growth factor receptor (FGFR) inhibitor. Also described herein are methods of selling or offering for sale an approved drug product containing a fibroblast growth factor receptor (FGFR) inhibitor.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 9, 2022
    Inventor: Peter Marie Z. DE PORRE
  • CANCER TREATMENT
    Publication number: 20220168298
    Abstract: The present invention provides a method for the treatment of cancer with erdafitinib in high-risk patients.
    Type: Application
    Filed: February 11, 2020
    Publication date: June 2, 2022
    Inventors: Anne Elizabeth O'HAGAN, Peter Marie Z. DE PORRE, Anjali Narayan AVADHANI
  • Cancer Treatment
    Publication number: 20220110935
    Abstract: The present invention provides a method for the treatment of cancer with erdafitinib.
    Type: Application
    Filed: June 28, 2021
    Publication date: April 14, 2022
    Inventors: Kim Stuyckens, Juan Jose Perez Ruixo, Peter Marie Z. De Porre, Anjali Narayan Avadhani, Yohann Loriot, Arlene O. Siefker-Radtke
  • Cancer treatment
    Patent number: 11077106
    Abstract: The present invention provides a method for the treatment of cancer with erdafitinib.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: August 3, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Kim Stuyckens, Juan Jose Perez Ruixo, Peter Marie Z. De Porre, Anjali Narayan Avadhani, Yohann Loriot, Arlene O. Siefker-Radtke
  • CANCER TREATMENT
    Publication number: 20200022976
    Abstract: The present invention provides a method for the treatment of cancer with erdafitinib.
    Type: Application
    Filed: February 2, 2018
    Publication date: January 23, 2020
    Inventors: Kim STUYCKENS, Juan Jose PEREZ RUIXO, Peter Marie Z. DE PORRE, Anjali Narayan AVADHANI, Yohann LORIOT, Arlene O. SIEFKER-RADTKE